These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9829018)

  • 1. Abecarnil, a new beta-carboline, in the treatment of anxiety disorders.
    Aufdembrinke B
    Br J Psychiatry Suppl; 1998; (34):55-63. PubMed ID: 9829018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder.
    Ballenger JC; McDonald S; Noyes R; Rickels K; Sussman N; Woods S; Patin J; Singer J
    Psychopharmacol Bull; 1991; 27(2):171-9. PubMed ID: 1681563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder.
    Ballenger JC; McDonald S; Noyes R; Rickels K; Woods SW; Patin J; Lydiard B; Garvey M; Cook B; Goodard AW
    Adv Biochem Psychopharmacol; 1992; 47():431-47. PubMed ID: 1354920
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.
    Steppuhn KG; Schneider HH; Turski L; Stephens DN
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1395-400. PubMed ID: 8095551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C; Chabannes JP; Saviuc P
    Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
    Löscher W; Hönack D; Scherkl R; Hashem A; Frey HH
    J Pharmacol Exp Ther; 1990 Nov; 255(2):541-8. PubMed ID: 1978730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder.
    Rickels K; DeMartinis N; Aufdembrinke B
    J Clin Psychopharmacol; 2000 Feb; 20(1):12-8. PubMed ID: 10653203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST; Park JH; Kim M
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.
    Mumford GK; Rush CR; Griffiths RR
    J Pharmacol Exp Ther; 1995 Feb; 272(2):570-80. PubMed ID: 7853170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the therapeutic action of alpidem in anxiety disorders: an overview of the European data.
    Morselli PL
    Pharmacopsychiatry; 1990 May; 23 Suppl 3():129-34. PubMed ID: 1974073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.
    Ozawa M; Sugimachi K; Nakada-Kometani Y; Akai T; Yamaguchi M
    J Pharmacol Exp Ther; 1994 May; 269(2):457-62. PubMed ID: 7910208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram therapy for major depression and anxiety disorders.
    Baldwin DS; Reines EH; Guiton C; Weiller E
    Ann Pharmacother; 2007 Oct; 41(10):1583-92. PubMed ID: 17848424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial.
    Allgulander C; Jørgensen T; Wade A; François C; Despiegel N; Auquier P; Toumi M
    Curr Med Res Opin; 2007 Oct; 23(10):2543-9. PubMed ID: 17825130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.